NCT04339881 (NODS-Cov2) is a clinical trial in Sars-CoV2, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT04339881?

NCT04339881 is sponsored by Assistance Publique - Hôpitaux de Paris.

Is NCT04339881 still recruiting?

NCT04339881 is currently completed. Last updated 23 November 2020.

Last reviewed 2020-11-23 · How we verify

NCT04339881: NODS-Cov2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

NOsocomial Dissemination Risk of SARS-Cov2

Completed Last updated 23 November 2020

What this trial tests

trial in Sars-CoV2 in 2,523 participants. Completed in 12 July 2020.

Timeline

17 April 2020

Primary endpoint
10 July 2020

12 July 2020

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,523
Start date	17 April 2020
Primary completion	10 July 2020
Estimated completion	12 July 2020
Sites	1 location across France

Conditions studied

Sars-CoV2 — all drugs for Sars-CoV2 →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Eligibility, any sex, with Sars-CoV2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To date, in France, in the context of the SARS Cov2 pandemic,both the number of affected subjects and the number of severe forms requiring hospital care are increasing. Several nosocomial transmission clusters have already been identified in hospitals (both pediatric and adult) but there is still limited data on the nosocomial spread of SARS-Cov2. This nosocomial transmission affects both patients and caregivers. It is important to understand the spread of the virus within the hospital. This will help to optimize procedures to prevent transmission to caregivers and hospitalizedpatients not infected with SARS Cov2, and more generally this will contribute to control the spread of SARS Cov2 in the community

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers.
Abbas M, Robalo Nunes T, Martischang R, Zingg W, et al · · 2021 · cited 197× · PMID 33407833 · DOI 10.1186/s13756-020-00875-7

Verify or expand the search:

Other recruiting trials for Sars-CoV2

Currently open trials in the same condition.

NCT04466683 — Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia · Phase 2 · active not recruiting
NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
NCT04363853 — Tocilizumab Treatment in Patients With COVID-19 · Phase 2 · active not recruiting
NCT04424992 — The Natural History of Hospitalized COVID-19 Patients · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04339881 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 23 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04339881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing